http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014115845-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2012-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2014115845-A
titleOfInvention COMPOSITIONS AND METHODS FOR TREATING STATES OF DISTURBED BARRIER FUNCTION OF SKIN
abstract 1. A method of treating a dermatological disorder in a subject in need thereof, comprising: applying to the subject a composition comprising a) a reactive reinforcing component and b) a crosslinking component, said crosslinking component facilitating in situ crosslinking of the reactive reinforcing component so that a film forms on the skin, thereby healing dermatological disease. 2. The method of claim 1, wherein the dermatological disorder is simple chronic lichen, lupus erythematosus, psoriasis, eczema, chronically dry skin, xeroderma, redheads and ichthyosis, or an ulcer, or any combination thereof. A method according to claim 1 or 2, wherein the film is used in combination with one or more additional therapeutic agents. The method of claim 3, wherein the additional therapeutic agent is a moisturizer, mineral oil, liquid paraffin, tar, anthralin, corticosteroids, fluocinonide, vitamin D3 analogues, retinoids, phototherapy, methotrexate, cyclosporine, monoclonal antibody, pimecrolimus, tacrolimus, azathioprine, azathioprine , salicylic acid, benzoyl peroxide, antibiotics or alpha hydroxy acids. 5. The method of claim 1, wherein the film has the appearance of natural skin. A method according to claim 1, wherein the reactive reinforcing component has a viscosity of from about 50,000 to 500,000 cSt or cP at 25 ° C. The method of claim 1, wherein the reactive reinforcing component is characterized by a ratio of vinyl groups to hydride functional groups of from about 1:10 to about 1: 100.8. The method of claim 1, wherein said reactive reinforcing component comprises a reaction
priorityDate 2011-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6509979
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID681445
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID681445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407866317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17760531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458433298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410542430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71380978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426116329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410862584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939

Total number of triples: 59.